Breaking News Instant updates and real-time market news.

BSX

Boston Scientific

$38.98

0.5 (1.30%)

08:39
10/02/18
10/02
08:39
10/02/18
08:39

Boston Scientific price target raised to $48 from $38 at Morgan Stanley

Morgan Stanley analyst David Lewis raised his price target on Boston Scientific shares to $48 from $38 as he believes the company's recent deal activity reflects an accelerating M&A climate, maturing venture portfolio and upcoming access to $2B in annual free cash flow and does not suggest a weakening of its core business. His deal by deal analysis suggests management's assumptions for the contributions from M&A appear conservative, added Lewis, who keeps an Overweight rating on Boston Scientific.

  • 09

    Oct

  • 24

    Oct

BSX Boston Scientific
$38.98

0.5 (1.30%)

09/04/18
09/04/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UPS (UPS) upgraded to Strong Buy from Market Perform at Raymond James with analyst Patrick Tyler Brown saying he believes investors are underappreciating UPS' long-term Domestic EBIT and 2021 free cash flow outlook, which could be greater than $8B. 2. Qualcomm (QCOM) upgraded to Outperform from Neutral at Macquarie with analyst Srini Pajjuri saying he believes risk/reward is attractive and sees multiple catalysts ahead including a final settlement with Huawei in the near future, increasing probability of an Apple (AAPL) settlement, and a 5G cycle that is not fully reflected in consensus estimates. 3. Albemarle (ALB) upgraded to Buy from Hold at SunTrust with analyst James Sheehan saying investors have driven down the price of the stock amid lithium oversupply concern on incorrect assumption that it is a commodity. 4. Univar (UNVR) upgraded to Buy from Hold at Berenberg with analyst Thomas Burlton saying the company is improving its conversion margin and EBITDA growth while its cash generation is also getting better. 5. Boston Scientific (BSX) upgraded to Buy from Hold at Jefferies with analyst Raj Denhoy citing a survey of 25 U.S. transcatheter aortic valve replacement doctors to gauge interest in tBoston Scientific's Lotus value. While feedback was better for Edwards Lifesciences (EW) and Medtronic's (MDT) valves, the majority of respondents were still interested in trying Lotus and expected the valve to capture 16%-18% share of the market. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/05/18
ARGS
09/05/18
NO CHANGE
Target $41
ARGS
Buy
Boston Scientific price target raised to $41 from $36 at Argus
Argus analyst Jasper Hellweg raised his price target on Boston Scientific to $41 and kept his Buy rating, saying the company's outperformance over the past 3 months has been driven by its new product and acquisition news. Hellweg further cites the company's Q2 results showing organic sales growth up in all 3 of its sectors and across all regions. The analyst also notes that the stock price is trading in a bullish pattern of higher lows and highs going back to 2012 and believes that Boston Scientific is deserving of its premium valuation based on its growth outlook and profitability profile.
09/10/18
NEED
09/10/18
NO CHANGE
Target $43
NEED
Strong Buy
Boston Scientific price target raised to $43 from $39 at Needham
Needham analyst Mike Matson raised his price target on Boston Scientific to $43 and kept his Strong Buy rating. The analyst cites the company's latest $500M bid Augmenix, whose SpaceOAR reduces side effects associated with prostate radiotherapy. While the company expects "immaterial" earnings impact from the deal through 2019, Matson believes that it will strengthen its Urology & Pelvic Health business longer term, with added potential "revenue synergies given BSX's NxThera acquisition and legacy GreenLight XPS system".
09/28/18
JEFF
09/28/18
NO CHANGE
Target $300
JEFF
Buy
Jefferies boosts Teleflex, Boston Scientific targets after urologist survey
Jefferies analyst Raj Denhoy raised his estimates for Teleflex (TFX) and Boston Scientific (BSX) after conducting a survey of 50 U.S.-based urologists to better understand demand and utilization trends for Teleflex's recently acquired UroLift and Boston Scientific's recently acquired Rezum System. He found that UroLift is 15% of procedure mix and expected to reach 25% in two years, and that current mix for Rezum is 10% and expected to be 20% in two years. UroLift taking share from all other modalities including drug therapy while Rezum is gaining share from surgery/ablation, Denhoy tells investors in a research note. The analyst increased his price target for Teleflex to $300 and for Boston Scientific to $45. He keeps Buy rating on both stocks.

TODAY'S FREE FLY STORIES

HBAN

Huntington Bancshares

$13.66

-0.54 (-3.80%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Huntington Bancshares to make targeted investments in people, technology »

Says local economies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

YMAB

Y-mAbs Therapeutics

$22.00

0.02 (0.09%)

09:27
10/23/18
10/23
09:27
10/23/18
09:27
Hot Stocks
Y-mAbs Therapeutics receives recommendation from COMP for OMPD for naxitamab »

Y-mAbs Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.84

0.02 (0.29%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Upgrade
Snap rating change  »

Snap upgraded to Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

PINC

Premier

$45.14

0.34 (0.76%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Hot Stocks
Adventist Health engages Premier in strategic supply chain initiative »

Adventist Health is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRPX

Therapix Biosciences

$4.39

0.08 (1.86%)

09:26
10/23/18
10/23
09:26
10/23/18
09:26
Hot Stocks
Therapix Biosciences to be acquired by FDS Pharma in $48M stock deal »

FSD Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$33.52

-0.77 (-2.25%)

09:25
10/23/18
10/23
09:25
10/23/18
09:25
Technical Analysis
Technical Take: Applied Materials drops to new 52-week low, analyst action »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFF

Griffon

$14.50

0.04 (0.28%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Griffon subsidiary awarded $23.5M contract by NAVAIR »

Telephonics, a wholly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$54.96

0.07 (0.13%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Verizon says 'confident' wireless business will continue to grow »

Says expects to continue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Nov

  • 13

    Nov

DSX

Diana Shipping

$3.86

0.05 (1.31%)

09:24
10/23/18
10/23
09:24
10/23/18
09:24
Hot Stocks
Diana Shipping to extend time charter contract for Electra with Uniper Global »

Diana Shipping announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

$36.24

0.38 (1.06%)

, PF

Pinnacle Foods

$66.61

0.29 (0.44%)

09:23
10/23/18
10/23
09:23
10/23/18
09:23
Hot Stocks
Pinnacle Foods' shareholders approved acquisition by Conagra Brands »

Conagra Brands (CAG) and…

CAG

Conagra Brands

$36.24

0.38 (1.06%)

PF

Pinnacle Foods

$66.61

0.29 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

QCOM

Qualcomm

$66.08

0.72 (1.10%)

, AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

09:23
10/23/18
10/23
09:23
10/23/18
09:23
Hot Stocks
Amazon, Qualcomm to put Alexa assistant in more headphones »

Qualcomm (QCOM) said in a…

QCOM

Qualcomm

$66.08

0.72 (1.10%)

AMZN

Amazon.com

$1,789.00

25.09 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

ACB

Aurora Cannabis

$0.00

(0.00%)

, ACBFF

Aurora Cannabis

$0.00

(0.00%)

09:22
10/23/18
10/23
09:22
10/23/18
09:22
Hot Stocks
Aurora Cannabis to commence trading on NYSE today »

Aurora Cannabis will…

ACB

Aurora Cannabis

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$261.03

0.97 (0.37%)

09:21
10/23/18
10/23
09:21
10/23/18
09:21
Recommendations
Tesla analyst commentary  »

Tesla shares could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 13

    Dec

HAL

Halliburton

$36.36

-1.18 (-3.14%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Recommendations
Halliburton analyst commentary  »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$93.62

-0.28 (-0.30%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Hot Stocks
Medtronic announces FDA approval for Valiant Navion thoracic stent graft system »

Medtronic announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$138.68

-0.32 (-0.23%)

, ITCI

Intra-Cellular

$17.21

-1.02 (-5.60%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Conference/Events
JPMorgan pharma and biotech analysts to hold analyst/industry conference call »

Smid Cap Biotech Analyst…

JNJ

Johnson & Johnson

$138.68

-0.32 (-0.23%)

ITCI

Intra-Cellular

$17.21

-1.02 (-5.60%)

AGN

Allergan

$187.75

-1.87 (-0.99%)

SAGE

Sage Therapeutics

$118.03

-4.29 (-3.51%)

ALKS

Alkermes

$38.86

-1.34 (-3.33%)

ACAD

Acadia

$21.77

-0.46 (-2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 19

    Dec

  • 31

    Jan

EIGR

Eiger BioPharmaceuticals

$10.65

-1.2 (-10.13%)

09:20
10/23/18
10/23
09:20
10/23/18
09:20
Syndicate
Eiger BioPharmaceuticals 4.2M share Spot Secondary priced at $10.35 »

BTIG acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 23

    Oct

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
10/23/18
10/23
09:18
10/23/18
09:18
Options
Overnight activity included 825 trades in SPX and 119 trades in VIX »

825 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$31.20

-0.25 (-0.79%)

, F

Ford

$8.41

0.06 (0.72%)

09:17
10/23/18
10/23
09:17
10/23/18
09:17
Hot Stocks
Avis Budget, Ford announce agreement to connect fleet vehicles »

Avis Budget (CAR)…

CAR

Avis Budget

$31.20

-0.25 (-0.79%)

F

Ford

$8.41

0.06 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 13

    Dec

NCR

NCR Corp.

, JTPY

JetPay

$4.97

2.9 (140.10%)

09:15
10/23/18
10/23
09:15
10/23/18
09:15
Recommendations
NCR Corp., JetPay analyst commentary  »

NCR Corp. deal for JetPay…

NCR

NCR Corp.

JTPY

JetPay

$4.97

2.9 (140.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 26

    Nov

  • 29

    Nov

CADE

Cadence Bancorp

$21.65

-0.27 (-1.23%)

09:15
10/23/18
10/23
09:15
10/23/18
09:15
Recommendations
Cadence Bancorp analyst commentary  »

Cadence Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 06

    Dec

09:15
10/23/18
10/23
09:15
10/23/18
09:15
General news
Breaking General news story  »

Minneapolis Federal…

CMP

Compass Minerals

$68.01

-0.08 (-0.12%)

09:14
10/23/18
10/23
09:14
10/23/18
09:14
Earnings
Compass Minerals sees FY18 EPS $2.20-$2.50, consensus $2.83 »

Compass Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

FITB

Fifth Third

$25.38

-0.95 (-3.61%)

09:14
10/23/18
10/23
09:14
10/23/18
09:14
Hot Stocks
Breaking Hot Stocks news story on Fifth Third »

Fifth Third says at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

HPQ

HP Inc.

$24.11

0.26 (1.09%)

09:13
10/23/18
10/23
09:13
10/23/18
09:13
Hot Stocks
HP Inc., NTU Singapore and NRF collaborate on corporate innovation lab »

Nanyang Technological…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.